Great outcome for patients and are now able to increase the dose to see whether it helps cancer patients to recover.
Whoever is writing these articles though needs to understand the audience reading them. Poorly written IMHO, and needs to be updated to highlight key findings in a table or similar - but we already know these guys are scientists not business men / women.
